TY - JOUR
T1 - Konsensuspapier der Deutschen Gesellschaft für Kardiologie (DGK) und der Deutschen Gesellschaft für Thorax‑, Herz- und Gefäßchirurgie (DGTHG) zur kathetergestützten Aortenklappenimplantation (TAVI) 2020
AU - Kuck, Karl Heinz
AU - Bleiziffer, Sabine
AU - Eggebrecht, Holger
AU - Ensminger, Stephan
AU - Frerker, Christian
AU - Möllmann, Helge
AU - Nef, Holger
AU - Thiele, Holger
AU - Treede, Hendrik
AU - Wimmer-Greinecker, Gerhard
AU - Walther, Thomas
N1 - Funding Information:
Johann Bauersachs (Hannover), Andreas B?ning (Gie?en), Albrecht Els?sser (Oldenburg), Volkmar Falk (Berlin), Jan Gummert (Bad Oeynhausen), Christian Hamm (Gie?en), Michael Haude (Neuss), R?diger Lange (M?nchen), Hermann Reichenspurner (Hamburg), Thomas Schmitz (Essen), Andreas Zeiher (Frankfurt am Main)
Publisher Copyright:
© 2020, Deutsche Gesellschaft für Thorax-, Herz und Gefäßchirurgie (DGTHG) Published by Springer Medizin Verlag GmbH – all rights reserved.
Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2020/6/1
Y1 - 2020/6/1
N2 - Following the two position papers of the German Cardiac Society (DGK) from 2015 and 2016 on transcatheter aortic valve implantation (TAVI), the DGK and the German Society for Thoracic and Cardiovascular Surgery (DGTHG) have decided to issue a consensus paper on the topic that takes into account the most recent results from randomized controlled trials and registries, with special emphasis on patients with severe aortic stenosis (AS) and low operative risk (STS score ≤4%). Specific indications, such as “valve in valve” and severe AS in patients with a bicuspid aortic valve are also addressed. Additionally, TAVI-related complications and the durability of percutaneously in comparison to surgically inserted prostheses are discussed, particularly in view of the generally younger age of low-risk patients. According to this consensus paper, surgical aortic valve replacement (SAVR) is recommended for low-risk patients ≤70 years without any of the risk factors known to be missing from the widely accepted risk scores. The TAVI procedure is recommended after heart team consensus for low-risk patients >75 years and a suitable anatomy for TAVI. In patients between 70 and 75 years old, a heart team decision between SAVR and TAVI is recommended that considers the patient’s life perspective in view of missing long-term data from randomized trials. Taking into account the decision of the Federal Joint Committee (G-BA) on percutaneous heart valve treatment, the personnel and structural prerequisites regarding the qualification of TAVI centers and TAVI surgeons, with the special roles of interventional cardiologists and cardiac surgeons, are defined.
AB - Following the two position papers of the German Cardiac Society (DGK) from 2015 and 2016 on transcatheter aortic valve implantation (TAVI), the DGK and the German Society for Thoracic and Cardiovascular Surgery (DGTHG) have decided to issue a consensus paper on the topic that takes into account the most recent results from randomized controlled trials and registries, with special emphasis on patients with severe aortic stenosis (AS) and low operative risk (STS score ≤4%). Specific indications, such as “valve in valve” and severe AS in patients with a bicuspid aortic valve are also addressed. Additionally, TAVI-related complications and the durability of percutaneously in comparison to surgically inserted prostheses are discussed, particularly in view of the generally younger age of low-risk patients. According to this consensus paper, surgical aortic valve replacement (SAVR) is recommended for low-risk patients ≤70 years without any of the risk factors known to be missing from the widely accepted risk scores. The TAVI procedure is recommended after heart team consensus for low-risk patients >75 years and a suitable anatomy for TAVI. In patients between 70 and 75 years old, a heart team decision between SAVR and TAVI is recommended that considers the patient’s life perspective in view of missing long-term data from randomized trials. Taking into account the decision of the Federal Joint Committee (G-BA) on percutaneous heart valve treatment, the personnel and structural prerequisites regarding the qualification of TAVI centers and TAVI surgeons, with the special roles of interventional cardiologists and cardiac surgeons, are defined.
UR - http://www.scopus.com/inward/record.url?scp=85085490191&partnerID=8YFLogxK
U2 - 10.1007/s00398-020-00373-3
DO - 10.1007/s00398-020-00373-3
M3 - Zeitschriftenaufsätze
AN - SCOPUS:85085490191
SN - 0930-9225
VL - 34
SP - 194
EP - 213
JO - Zeitschrift fur Herz-, Thorax- und Gefäßchirurgie
JF - Zeitschrift fur Herz-, Thorax- und Gefäßchirurgie
IS - 3
ER -